[The decision to treat moderate XXXX : repetition of office visits or ambulatory monitoring of arterial pressure?].

@entity1 @entity101 @entity349 @entity13520 @entity551 @entity11015
World Health Organization (WHO) recommends antihypertensive therapy for mild to moderate @entity101 @entity1 after 3 or more visits. We tested the hypothesis that an ambulatory blood pressure recording could also help to decide which @entity1 need therapy. Blood pressure was measured in 89 essential, uncomplicated, @entity101 @entity1 (diastolic ( @entity13520 ): 90-110 mmHg, mean age: 41 +/- 13 years), with a @entity349 sphygmomanometer at 3 visits and with an ambulatory blood pressure recorder (Spacelabs) during 12 hours. According to WHO recommendations, @entity1 were classified "WHO+" if they need a treatment (n = 44) and "WHO-" if they did not. The mean ambulatory @entity13520 of each subject was compared to the arbitrary limit defined as the mean +2 standard deviations of the ambulatory @entity13520 of a population of normotensive subjects in the same decade and same sex: @entity1 with ambulatory @entity13520 above this limit were defined " @entity11015 +" (n = 27), the others were " @entity11015 -". Ten @entity1 were "WHO- @entity11015 +" and 24 were "WHO+ @entity11015 -". These discordances were independent of age, body weight, duration of @entity101 , @entity551 defined by the standard deviation. By contrast, the difference between the measurements of the simultaneous blood pressure measurements performed with the two methods ( @entity349 sphyngmomanometer and Spacelabs) 2 times by each @entity1 could explain in part these discrepancies. The Spacelabs underestimates @entity13520 measured with the @entity349 sphyngmomanometer in @entity1 " @entity11015 -" but not in @entity1 " @entity11015 +".(ABSTRACT TRUNCATED AT 250 WORDS)
